TAK1 signaling in skeletal muscle
骨骼肌中的 TAK1 信号传导
基本信息
- 批准号:10201515
- 负责人:
- 金额:$ 42.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAgingAtrophicAutophagocytosisAutophagosomeBiochemicalBiogenesisBiological AssayBirthChronic DiseaseCommunicationComplexComplicationDataDenervationDiseaseEquilibriumEtiologyFundingGeneticGrowthGrowth FactorHealthHomeostasisHumanHypertrophyImmobilizationImpairmentInhibition of ApoptosisInjuryKnockout MiceKyphosis deformity of spineLeadLifeLoxP-flanked alleleMAPK Signaling Pathway PathwayMaintenanceMediatingMitochondriaMolecularMolecular BiologyMusMuscleMuscle DevelopmentMuscle functionMuscle satellite cellMuscular AtrophyMuscular DystrophiesMyoblastsNatural regenerationNatureOxidation-ReductionOxidative StressPathway interactionsPharmaceutical PreparationsPhasePhosphorylationPhosphotransferasesPopulationPreventionProductionProtein BiosynthesisProteinsReactive Oxygen SpeciesRegulationReportingRespiratory physiologyRoleSignal PathwaySignal TransductionSignaling ProteinSkeletal MuscleStarvationStimulusStructureSyndromeTNF receptor-associated factor 6TamoxifenTestingTransforming Growth Factorsbasecell typeconditional knockoutexperimental studyimprovedmTOR Signaling Pathwaymitochondrial dysfunctionmouse modelmuscle formmuscle hypertrophymuscle regenerationnew therapeutic targetnovelpreventprotein degradationresponsesatellite cellself-renewalskeletal muscle growthskeletal muscle wastingwasting
项目摘要
Abstract
Loss of skeletal muscle mass is a devastating complication of a wide range of diseases and
conditions. However, there is still no approved therapy to prevent muscle wasting partly because the
mechanisms that regulate skeletal muscle mass remain enigmatic. Accumulating evidence suggests
that an array of signaling pathways regulates skeletal muscle mass mainly through modulating the
rate of protein synthesis and degradation. However, upstream signaling mechanisms that are involved
in the regulation of muscle mass remain poorly understood. During the current funding of this project,
we showed TRAF6 mediates muscle atrophy and inhibits muscle regeneration in a variety of catabolic
conditions. We also demonstrated that TRAF6 and TAK1 are important regulators of satellite cell
homeostasis in adult skeletal muscle. In contrast to TRAF6, of which activation, causes muscle
wasting, we have discovered that TAK1 is essential for skeletal muscle growth and maintenance of
muscle mass in adults. Inducible myofiber-specific inactivation of TAK1 in mice (henceforth TAK1mko)
leads to severe muscle wasting and development of kyphosis. The positive role of TAK1 in muscle
growth is also supported by our findings that the activation of TAK1 is dramatically increased in
skeletal muscle undergoing hypertrophy. Our experiments also suggest that TAK1 is required for the
activation of specific intracellular pathways which promote skeletal muscle growth. Moreover, our
studies indicate that TAK1 may be required for the activation of autophagy/mitophagy, regulation of
mitochondrial structure and function, and maintenance of redox balance in skeletal muscle of adults.
Based on our preliminary data, we hypothesize that (I) TAK1 promotes skeletal muscle growth and
inhibits atrophy through augmenting protein synthesis and preventing oxidative stress; (II) TAK1
induces the activation of specific intracellular signaling pathways to augment skeletal muscle mass;
and (III) TAK1 is required for the activation of autophagy/mitophagy and regulation of mitochondrial
dynamics (i.e. biogenesis, fusion, and fission) and respiratory function in adult skeletal muscle. To test
these hypotheses, in the next phase of the project, we propose to address the following three specific
aims: (1) Establish the role and investigate the molecular mechanisms by which TAK1 promotes
skeletal muscle growth and prevents atrophy; (2) Investigate the signaling mechanisms by which
TAK1 regulates skeletal muscle mass; and (3) Investigate the role of TAK1 in regulation of autophagy
and mitochondrial content and function in adult skeletal muscle.
摘要
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Estrogen-Related Receptor Gamma Gene Therapy Promotes Therapeutic Angiogenesis and Muscle Recovery in Preclinical Model of PAD.
- DOI:10.1161/jaha.122.028880
- 发表时间:2023-08-15
- 期刊:
- 影响因子:5.4
- 作者:Sopariwala, Danesh H. H.;Rios, Andrea S. S.;Saley, Addison;Kumar, Ashok;Narkar, Vihang A. A.
- 通讯作者:Narkar, Vihang A. A.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ASHOK KUMAR其他文献
ASHOK KUMAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ASHOK KUMAR', 18)}}的其他基金
TWEAK/Fn14/UPR Signaling in Skeletal Muscle Wasting
骨骼肌萎缩中的 TWEAK/Fn14/UPR 信号转导
- 批准号:
10660397 - 财政年份:2023
- 资助金额:
$ 42.97万 - 项目类别:
Non-Coding Variants of Angiotensinogen Gene and Hypertension
血管紧张素原基因的非编码变异与高血压
- 批准号:
9197334 - 财政年份:2016
- 资助金额:
$ 42.97万 - 项目类别:
Non-Coding Variants of Angiotensinogen Gene and Hypertension
血管紧张素原基因的非编码变异与高血压
- 批准号:
9325162 - 财政年份:2016
- 资助金额:
$ 42.97万 - 项目类别:
MYD88 Signaling in Mammalian Myoblast Fusion
哺乳动物成肌细胞融合中的 MYD88 信号转导
- 批准号:
9144184 - 财政年份:2015
- 资助金额:
$ 42.97万 - 项目类别:
MYD88 Signaling in Mammalian Myoblast Fusion
哺乳动物成肌细胞融合中的 MYD88 信号转导
- 批准号:
9336240 - 财政年份:2015
- 资助金额:
$ 42.97万 - 项目类别:
TAK1/TRAF6 Signaling in Skeletal Muscle
骨骼肌中的 TAK1/TRAF6 信号传导
- 批准号:
8502172 - 财政年份:2011
- 资助金额:
$ 42.97万 - 项目类别:
相似海外基金
Investigating HDAC3 phosphorylation as an epigenetic regulator of memory formation in the adult and aging brain
研究 HDAC3 磷酸化作为成人和衰老大脑记忆形成的表观遗传调节剂
- 批准号:
10752404 - 财政年份:2023
- 资助金额:
$ 42.97万 - 项目类别:
The Health of Aging Parents of Adult Children with Serious Conditions
患有严重疾病的成年子女的年迈父母的健康
- 批准号:
10660046 - 财政年份:2023
- 资助金额:
$ 42.97万 - 项目类别:
Understanding Longer-Living Older Adult Research: The Summer Program on Aging
了解长寿老年人研究:老龄化夏季项目
- 批准号:
476343 - 财政年份:2022
- 资助金额:
$ 42.97万 - 项目类别:
Role of sensory experience in the regulation of plasticity in the developing, adult and aging brain
感官体验在发育、成人和衰老大脑可塑性调节中的作用
- 批准号:
RGPIN-2019-04761 - 财政年份:2022
- 资助金额:
$ 42.97万 - 项目类别:
Discovery Grants Program - Individual
Adult Cognitive and Neurobiological Indicators of Aging: Impact of Adversity and Social Support
成人衰老的认知和神经生物学指标:逆境和社会支持的影响
- 批准号:
10365348 - 财政年份:2022
- 资助金额:
$ 42.97万 - 项目类别:
Adult Cognitive and Neurobiological Indicators of Aging: Impact of Adversity and Social Support
成人衰老的认知和神经生物学指标:逆境和社会支持的影响
- 批准号:
10700796 - 财政年份:2022
- 资助金额:
$ 42.97万 - 项目类别:
Endogenous barcoding to determine complex dynamics of adult neurogenesis in aging and Alzheimer's disease
内源条形码确定衰老和阿尔茨海默病中成人神经发生的复杂动态
- 批准号:
10651861 - 财政年份:2022
- 资助金额:
$ 42.97万 - 项目类别:
Investigating the interface of epigenetics and metabolism underlying memory formation in the adult, aging, and AD brain
研究成人、衰老和 AD 大脑中记忆形成的表观遗传学和代谢界面
- 批准号:
10420533 - 财政年份:2022
- 资助金额:
$ 42.97万 - 项目类别:
Endogenous barcoding to determine complex dynamics of adult neurogenesis in aging and Alzheimer's disease
内源条形码确定衰老和阿尔茨海默病中成人神经发生的复杂动态
- 批准号:
10846200 - 财政年份:2022
- 资助金额:
$ 42.97万 - 项目类别:
THE DEVELOPMENT OF MECHANISM-BASED ADULT STEM CELL TREATMENTS TO COMBAT AGING PATHOLOGIES
开发基于机制的成人干细胞疗法来对抗衰老病理学
- 批准号:
10721544 - 财政年份:2022
- 资助金额:
$ 42.97万 - 项目类别:














{{item.name}}会员




